These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12242299)

  • 1. Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis.
    Roberts EC; Shapiro PS; Nahreini TS; Pages G; Pouyssegur J; Ahn NG
    Mol Cell Biol; 2002 Oct; 22(20):7226-41. PubMed ID: 12242299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit.
    Willard FS; Crouch MF
    Cell Signal; 2001 Sep; 13(9):653-64. PubMed ID: 11495723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1.
    Dangi S; Chen FM; Shapiro P
    Cell Prolif; 2006 Aug; 39(4):261-79. PubMed ID: 16872362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
    Piatelli MJ; Doughty C; Chiles TC
    J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase.
    Chiariello M; Gomez E; Gutkind JS
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):869-76. PubMed ID: 10903150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction pathways for activation of extracellular signal-regulated kinase by arachidonic acid in rat neutrophils.
    Chang LC; Wang JP
    J Leukoc Biol; 2001 Apr; 69(4):659-65. PubMed ID: 11310854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
    Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
    Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
    Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
    Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry into M-phase in cycling Xenopus egg extracts.
    Bitangcol JC; Chau AS; Stadnick E; Lohka MJ; Dicken B; Shibuya EK
    Mol Biol Cell; 1998 Feb; 9(2):451-67. PubMed ID: 9450967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravitreal insulin and insulin signaling cascade inhibitors on emmetropization in the chick.
    Penha AM; Burkhardt E; Schaeffel F; Feldkaemper MP
    Mol Vis; 2012; 18():2608-22. PubMed ID: 23112573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole.
    Hayne C; Tzivion G; Luo Z
    J Biol Chem; 2000 Oct; 275(41):31876-82. PubMed ID: 10884385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NGF promotes cell cycle progression by regulating D-type cyclins via PI3K/Akt and MAPK/Erk activation in human corneal epithelial cells.
    Hong J; Qian T; Le Q; Sun X; Wu J; Chen J; Yu X; Xu J
    Mol Vis; 2012; 18():758-64. PubMed ID: 22509106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
    Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM
    Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of mitosis-specific activation of MEK1.
    Harding A; Giles N; Burgess A; Hancock JF; Gabrielli BG
    J Biol Chem; 2003 May; 278(19):16747-54. PubMed ID: 12609978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdc2-mediated inhibition of epidermal growth factor activation of the extracellular signal-regulated kinase pathway during mitosis.
    Dangi S; Shapiro P
    J Biol Chem; 2005 Jul; 280(26):24524-31. PubMed ID: 15888452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine-phosphorylated extracellular signal--regulated kinase associates with the Golgi complex during G2/M phase of the cell cycle: evidence for regulation of Golgi structure.
    Cha H; Shapiro P
    J Cell Biol; 2001 Jun; 153(7):1355-67. PubMed ID: 11425867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
    Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
    J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin inhibits hepatic growth hormone receptor and insulin-like growth factor I mRNA expression by activating the ERK and PI3K signaling pathways.
    Hagemeister AL; Sheridan MA
    Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R490-7. PubMed ID: 18495839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.